John Gransee is an accomplished finance and business professional with over 30 years of experience in leadership roles within the healthcare industry. He currently serves as Senior Vice President and CFO of Covance, a $3 billion drug development services segment of LabCorp. Prior to this role, he held various VP roles at Covance and Baxter International, leading strategic initiatives, operations, and financial management. He has a proven track record of delivering cost savings, improving processes, and growing business.

1. JOHN R. GRANSEE
John.Gransee@Covance.com
SUMMARY
Accomplished finance and business professional with proven experience in general management, operations,
strategic planning, P&L/balance sheet ownership, business partnership and acquisition/divestiture analysis.
Able to successfully lead, communicate, and manage results and talent within highly matrixed organizations.
LABCORP – BURLINGTON, NORTH CAROLINA 2005 – Present
LabCorp is the world’s leading healthcare diagnostic company with ~$9billion in annual revenue.
Senior Vice President and CFO – Covance – Indianapolis, Indiana 2015 – Present
Covance is a ~$3billion drug development services segment of LabCorp providing early and late-stage product
development services to the pharmaceutical, biotechnology and medical device industries worldwide.
Chief Financial Officer and member of the Senior Executive Committee reporting directly to the CFO of
LabCorp with a strong dotted line into the CEO of Covance. Responsible for the strategic direction setting and
successful execution of the accounting, finance, planning, analysis, pricing and financial integration.
• Revamped reporting and analysis processes and requirements across the company to align with new
parent policies and to better facilitate decision making during the first year of integration. Reduced
earnings cycle reporting timelines by approximately one week.
• Redesigned organization to achieve over $2.5M in headcount savings while maintaining service levels.
• Partnering in the design and negotiations of a $700+M strategic relationship with a top ten pharma co.
• Co-leading process of implementing zero-based costing for all business partner functions.
Vice President – R&D Labs Sample Management & Archive Services and Vice President
Global Operations – Central Laboratory (CLS) – Indianapolis, Indiana 2013 – 2015
R&D Labs is a $1.8 billion collection of pre-clinical and clinical laboratory based businesses. CLS is a $1.1
billion world leader in clinical trial laboratory services and is the largest division within R&D Labs.
Head of Operations and member of the CLS Senior Leadership Committee reporting directly to the President of
CLS. Responsible for the strategic oversight and operational delivery of over 700 employees located in 18
locations across the globe. Disciplines include Kit Manufacturing, Logistics, Pre-Analytical Sample
Preparation, Biorepository Services, Call Center Services and Investigator Site Support.
• Developed business case, created global structure, harmonized operational procedures and optimized
commercial policies in the development of one R&D Labs Logistics, Sample Management and
Archiving organization saving in excess of $3M while increasing commercial opportunities.
• Saved over $38M through additional process improvements, vendor management, automation and
organizational design changes. Led division wide reduction in force and cost containment efforts.
• Executed a $9M automation project in Geneva, CH as well as multiple biorepository site expansions.
• Increased mid-size pharma company sales by 200% through hands on executive sponsorship.
Vice President – Global Finance – Early Development (ED) – Madison, Wisconsin 2011 – 2013
A $650 million division of Covance specializing in pre-clinical trial services.
Head of Finance and member of the ED Senior Leadership Committee reporting directly to the CFO of Covance
Inc. Responsible for the strategic oversight and financial direction of the division.

2. • Co-led core team in the development, financial justification, future organizational design and execution
of a major people/asset restructuring delivering $25+M annualized cost savings.
JOHN GRANSEE PAGE 2
• Created new costing model and pricing policy forum to increase profitable sales resulting in exited
product lines and better utilization of capacity.
• Developed new forecasting methodology, consolidated financial disciplines and upgraded global talent
to re-establish credibility.
Vice President & General Manager – Genomics Laboratory – Seattle, Washington 2009 – 2011
A $30 million commercial organization acquired from Merck.
Business leader for all operational and commercial activities of the organization reporting to the Discovery and
Translational Services Group Vice President.
• Transformed a pharma R&D cost center into a fully functioning stand-alone commercial operation.
• Pioneered development of commercial policies, pricing strategy and the five-year strategic plan.
• Helped grow client base from one to twenty-five while exceeding all financial targets.
• Directed the successful execution of obtaining CLIA accreditation and GLP compliant services.
• Restructured organization and major contracts to further enhance sustainability.
Vice President – Global Finance – Central Laboratory (CLS) – Indianapolis, Indiana 2005 – 2009
A $600 million world leader in clinical trial laboratory services.
Head of Finance reporting directly to the President of CLS and the CFO of Covance Inc. Responsible for the
strategic oversight and financial direction of the organization. Assumed additional responsibilities to lead the
strategic pricing and policy setting organization in addition to the accounting, finance, contracts, sourcing,
procurement, warehousing, resource management and client services teams.
• Led Pan-Covance initiative to develop the cost/benefit and strategic alternatives to implementing a
financial shared service center which was subsequently adopted and implemented.
• Drove cross-functional team to reduce DSO by over 20 days. Presented methodology to audit finance
committee and served as leader in helping to implement similar strategies in sister divisions.
• Helped pioneer Six-Sigma strategy as member of the steering, champion and finance committee.
Utilized DMAIC and Kaizen techniques to help drive millions of dollars in operational savings.
• Developed and implemented company wide finance entry management rotation program.
• First finance executive to win company- wide “People Achievement” award.
BAXTER INTERNATIONAL INC. - DEERFIELD, ILLINOIS 1989 – 2005
A $13 billion global healthcare company in the medication delivery, blood proteins, renal dialysis and blood
collection markets. Baxter employs over 50,000 individuals in over 100 locations.
Promoted through various financial and business partner roles of increasing responsibility/scope including
statutory accounting, manufacturing accounting, finance and business development. Extensive international
experience in Pan-Pacific and Western Europe regions, including a two-year expatriate assignment in Paris,
France.
EDUCATION/CERTIFICATIONS
Northwestern University – Kellogg School of Management – Evanston, Illinois 2005
Masters of Business Administration

3. Northern Illinois University – DeKalb, Illinois 1988
Bachelor of Science, Accounting
Certified Public Accountant 1989